Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/27/19
End: 05/15/21
Due: 05/15/22
Phase: N/A
Priority: Normal
Start: 02/16/22
End: 02/01/23
Due: 02/01/24
Phase: N/A
Priority: Normal
Start: 04/20/18
End: 10/23/20
Due: 10/23/21
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Study Investigating the Efficacy and Safety of Sepranolone in Women With Menstrual Migraine | NCT04102995 | Asarina Pharma | user2@example.com | None | 2019-08-27 | 2021-05-15 | 2022-05-15 | - | - | 2025-07-14 |
| A Study to Explore the Effect of Sepranolone in Tourette Syndrome | NCT05434546 | Asarina Pharma | user2@example.com | None | 2022-02-16 | 2023-02-01 | 2024-02-01 | - | - | 2025-07-14 |
| A Study of Efficacy and Safety of Sepranolone (UC1010) in Patients With Premenstrual Dysphoric Disorder (PMDD) | NCT03697265 | Asarina Pharma | user2@example.com | None | 2018-04-20 | 2020-10-23 | 2021-10-23 | - | - | 2025-07-14 |